Kevin Mclaughlin

Insider Reports History

Entity
Individual
Location
C/O Acceleron Pharma Inc., 128 Sidney Street, Cambridge, MA
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Mclaughlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp Director Common Stock 11.9K $547K $45.99 Aug 7, 2024 Direct
Vericel Corp Director Restricted Stock Unit 3.2K $57.6K $18.00 May 1, 2024 Direct
Invivyd, Inc. Director Stock Option (Right to Buy) 100K May 21, 2024 Direct
Vericel Corp Director Stock Option (Right to Buy) 13K Aug 7, 2024 Direct
ACCELERON PHARMA INC SVP, CFO and Treasurer Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC SVP, CFO and Treasurer Option to Purchase Common Stock 0 Nov 19, 2021 Direct
Decibel Therapeutics, Inc. Director Common Stock 0 $5.03 Sep 25, 2023 Direct
Decibel Therapeutics, Inc. Director Stock Option (right to buy) 0 Sep 25, 2023 Direct

Insider Reports Filed by Kevin Mclaughlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VCEL Vericel Corp Aug 7, 2024 6 -$295K 4 Aug 9, 2024 Director
IVVD Invivyd, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
IVVD Invivyd, Inc. May 21, 2024 0 $0 3 May 23, 2024 Director
VCEL Vericel Corp May 1, 2024 4 $0 4 May 3, 2024 Director
DBTX Decibel Therapeutics, Inc. Sep 25, 2023 3 $0 4 Sep 25, 2023 Director
DBTX Decibel Therapeutics, Inc. Jun 13, 2023 2 $0 4 Jun 14, 2023 Director
VCEL Vericel Corp May 3, 2023 2 $0 4 May 5, 2023 Director
VCEL Vericel Corp Apr 27, 2023 2 $0 4 Apr 28, 2023 Director
DBTX Decibel Therapeutics, Inc. Oct 10, 2022 1 $0 4 Oct 12, 2022 Director
DBTX Decibel Therapeutics, Inc. Oct 10, 2022 0 $0 3 Oct 12, 2022 Director
VCEL Vericel Corp Apr 27, 2022 4 $0 4 Apr 29, 2022 Director
XLRN ACCELERON PHARMA INC Nov 19, 2021 6 $0 4 Nov 22, 2021 SVP, CFO and Treasurer
XLRN ACCELERON PHARMA INC Sep 23, 2021 13 -$3.01M 4 Sep 24, 2021 SVP, CFO and Treasurer